Exponent Inc reports developments in science and engineering consulting, including financial results, client demand across its two operating segments, and capital-return actions. Its engineering and other scientific work includes failure analysis, dispute-related consulting, user research for consumer electronics, utility risk management, asset integrity, transportation, energy, construction, life sciences, and medical device support.
The company’s environmental and health segment is tied to chemical regulation, food safety, ecological and biological sciences, and environmental consulting. Recurring updates also cover quarterly dividends, share repurchase authorizations, conference calls, executive appointments, board matters, and governance changes.
Exponent (Nasdaq: EXPO) reported third-quarter revenue of $173.7 million, with earnings rising from the same period a year earlier. Revenue increased 18%, while revenue before reimbursements rose 12% to $153.1 million. Net income reached $30.9 million, or $0.64 per diluted share, versus $28.0 million, or $0.55. EBITDA, a non-GAAP earnings measure excluding taxes, interest income, depreciation and amortization, increased to $45.0 million; its margin on revenue before reimbursements rose to 29.4% from 28.3%.
Through the first three quarters, revenue rose 18% to $511.6 million and diluted earnings reached $1.83 versus $1.58. Exponent raised its full-year revenue and margin guidance: it expects revenue before reimbursements to grow 10%–11% and an EBITDA margin of 28.0%–28.3%. Fourth-quarter expectations are 8%–10% growth and a 26.3%–26.8% margin, respectively.
Exponent (EXPO) has declared a regular quarterly cash dividend of $0.31 per share of common stock for shareholders.
The dividend is payable on December 18, 2026, to common stockholders of record on December 4, 2026. Exponent expects to continue quarterly dividends, with future declarations and dates subject to its board’s final determination.
Exponent (EXPO) will report third-quarter fiscal 2026 financial results after the market closes on October 29, 2026. The results cover the period ended October 2, 2026. Management will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the business and financial results. A live and archived webcast will be available through the company's Investor Relations website.
Exponent (EXPO) hosted an Investor Day at its Phoenix Test and Engineering Center featuring leadership presentations and live research demonstrations. Presentations covered business drivers and opportunities involving artificial intelligence, data center infrastructure, energy and utilities, and chemicals of concern. A video of the presentations is available on the company’s investor relations website.
Exponent (Nasdaq: EXPO) reported second quarter 2026 revenues of $171.6 million, up 21% year over year, with revenues before reimbursements rising 12% to $148.9 million. Net income was $29.4 million, or $0.60 per diluted share, versus $26.6 million and $0.52 a year earlier. EBITDA increased to $42.7 million, representing a margin of 28.7% of revenues before reimbursements.
For the first half of 2026, revenues before reimbursements grew 11% to $300.7 million and net income reached $59.0 million ($1.19 diluted EPS). According to Exponent, it paid $31.3 million in dividends, repurchased $146.1 million of stock, declared a $0.31 quarterly dividend, and added $50 million to its repurchase authorization. The company raised 2026 guidance, now expecting revenues before reimbursements to grow 9%–10% and EBITDA margins of 27.8%–28.1%.
Exponent (Nasdaq: EXPO) announced that its Board of Directors declared a Q3 2026 quarterly cash dividend of $0.31 per share, payable on September 18, 2026 to stockholders of record on September 4, 2026. The Board also increased share repurchase authorization by $50 million, aligning with the company’s stated focus on returning capital to shareholders while investing for long-term growth.
Exponent (Nasdaq:EXPO) will release Second Quarter fiscal 2026 results for the period ended July 3, 2026, after market close on Thursday, July 30, 2026. Management will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss business and financial results.
Investors can access the live and archived webcast via the Investor Relations section of Exponent’s website and use the provided dial-in numbers or replay line and passcode through August 6, 2026.
Exponent (Nasdaq: EXPO) will host an Investor Day at its Phoenix Test & Engineering Center on September 29, 2026, at 8:30 a.m. PT. The half-day event will feature leadership presentations, facility tours, and live demonstrations of advanced testing, failure analysis, and multidisciplinary engineering capabilities.
Exponent (Nasdaq:EXPO) announced that CEO Dr. Catherine Corrigan, President John Pye, EVP Richard Schlenker, and CFO Eric Anderson will join a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference.
The session takes place on June 9, 2026, at 12:00 p.m. ET, with a live webcast and archived replay available on Exponent’s investor relations website.
Exponent (Nasdaq: EXPO) reported Q1 FY2026 results for the period ended April 3, 2026. Total revenues rose 14% to $166.3M and revenues before reimbursements rose 10% to $151.8M. Net income was $29.6M, or $0.59 diluted per share.
EBITDA was $43.1M (28.4% of net revenues). The company paid $16.6M in dividends, repurchased $78.8M of stock, ended the quarter with $118.6M cash, raised its buyback authorization by $50M, and maintained full-year guidance (high-single-digit revenue growth; EBITDA 27.6%–28.1% of revenues before reimbursements).